The reason for choosing the ACE2 gene in this study was that variants of this gene may be able to modulate intermolecular interactions with the S protein of SARS-CoV-2 and are associated with altering virulence, pathogenicity, clinical outcome, and COVID-19 susceptibility. This evidence concerns the gene PROS1 and COVID-19.